US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 50.060
  • +1.500+3.09%
Close Mar 11 16:00 ET
  • 50.010
  • -0.050-0.10%
Post 16:08 ET
3.16BMarket Cap-11.53P/E (TTM)

Rhythm Pharmaceuticals Key Stats

Rhythm Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 26, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
38.48M
41.83M
+3.35M
Beat Est.
+58.80%
+72.61%
+8.69%
EPS
-0.71
-0.72
-<0.01
Miss Est.
-1.57%
-2.86%
-1.28%
Strong Buy

Mar 7, 2025

Rhythm Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 44.961M--
--2025/Q1-- / 41.462M--
Feb 26, 20252024/Q441.830M / 38.484M--
Nov 5, 20242024/Q333.251M / 32.466M--
Aug 6, 20242024/Q229.078M / 28.790M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 44.961M--
--2025/Q1-- / 41.462M--
Feb 26, 20252024/Q441.830M / 38.484M--
Nov 5, 20242024/Q333.251M / 32.466M--
Aug 6, 20242024/Q229.078M / 28.790M--

Unlock Free Earnings Estimates

Rhythm Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 7, 2025

Strong Buy

  • Buy

    92.86%
  • Hold

    7.14%
  • Sell

    0.00%

Price Target

No Data